Source: Annual Congress 2013 –The multiple faces of stress in lung injury



Rating:

Share or cite this content

Citations should be made in the following way:
U. Farkhutdinov (Ufa, Russian Federation). Outcomes of antioxidant administration in experimentally induced pneumonia. Eur Respir J 2013; 42: Suppl. 57, 3906

Member's Comments

No comment yet.

Related content which might interest you: Benefits of co-administration of macrolides and glucocorticosteroids in the treatment of severe community acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Modification of empirical antibiotic therapy in community acquired pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Surfactant-enforced treatment of pseudomonas-induced pneumonia Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013 Effect of N-acetylcysteine on the activity of antibiotics against relevant respiratory pathogens Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Whether there are pharmacoeconomic and other advantages of using procalcitonin-guide antibacterial treatment in patients with severe community-acquired pneumonia in developing countries? Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Investigation of gram positive antibiotics as aerosol administration (cubicin, vancomycin, zyvoxid) Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Effects of ulinastatin in treatment of invasive candidiasis Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Development of an antibody therapy for the treatment of pneumonia Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections Year: 2016 Factors affecting treatment success in community acquired pneumonia (CAP) Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014 Direct costs of treating community-acquired pneumonia do not necessarily correlate with clinical severity Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes Year: 2015 Comparative evaluation of timing of antibiotic intravenous-to-oral switch in pneumonia Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options Year: 2014 Effect of inhaled steroid therapy on treatment response in hosptalized pneumonia patients: Results from Turkish Thoracic Society database Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 30 day mortality and eosinopenia in patients with pneumonia Source: International Congress 2014 – Different interesting issues in respiratory infections: 1 Year: 2014 Lung inflammation was attenuated by sakuranetin treatment in a model of acute lung injury Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Severity scores and management of community acquired pneumonia Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 The efficacy of adjuvant use low molecular weight heparins in patients with community-acquired pneumonia Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013 Could the early administration of antibiotics before admission improve the prognosis of pneumonia? Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015